Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 591,335Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Biophore India Pharmaceuticals Pvt Ltd

02 1Bachem AG

03 1USV Private Limited

04 1TAPI Technology & API Services

05 1Alembic Pharmaceuticals Limited

06 1AmbioPharm

07 1Auro Peptides Limited

08 1BCN Peptides

09 1Chengdu Shengnuo Biopharm

10 1Cipla

11 1Fresenius Kabi AB Brunna

12 1Hansoh Pharma

13 1MSN Laboratories

14 1Sun Pharmaceutical Industries Limited

15 1Viatris

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

GDUFA

DMF Review : Complete

Rev. Date : 2016-12-21

Pay. Date : 2016-09-27

DMF Number : 30526

Submission : 2016-09-27

Status : Active

Type : II

Biophore

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 20862

Submission : 2007-09-17

Status : Active

Type : II

Bachem company banner

03

The Generic Rx Session
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothUSV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.

GDUFA

DMF Review : Complete

Rev. Date : 2019-02-08

Pay. Date : 2018-12-03

DMF Number : 33212

Submission : 2018-12-07

Status : Active

Type : II

USV Private Limited

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

GDUFA

DMF Review : Complete

Rev. Date : 2016-07-06

Pay. Date : 2016-04-28

DMF Number : 30476

Submission : 2016-06-09

Status : Active

Type : II

TAPI Company Banner

05

The Generic Rx Session
Not Confirmed

06

The Generic Rx Session
Not Confirmed

07

The Generic Rx Session
Not Confirmed

07

The Generic Rx Session
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2015-06-30

Pay. Date : 2015-03-30

DMF Number : 28496

Submission : 2015-03-09

Status : Active

Type : II

blank

08

The Generic Rx Session
Not Confirmed

09

The Generic Rx Session
Not Confirmed

10

The Generic Rx Session
Not Confirmed

Looking for 138614-30-9 / Icatibant Acetate API manufacturers, exporters & distributors?

Icatibant Acetate manufacturers, exporters & distributors 1

72

PharmaCompass offers a list of Icatibant Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Icatibant Acetate manufacturer or Icatibant Acetate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Icatibant Acetate manufacturer or Icatibant Acetate supplier.

PharmaCompass also assists you with knowing the Icatibant Acetate API Price utilized in the formulation of products. Icatibant Acetate API Price is not always fixed or binding as the Icatibant Acetate Price is obtained through a variety of data sources. The Icatibant Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Icatibant Acetate

Synonyms

Icatibant acetate [usan], Icatibant (acetate), Firazyr, 325o8467xk, 138614-30-9, (r)-arginyl-(s)-arginyl-(s)-prolyl-(2s,4r)-(4-hydroxyprolyl)glycyl-(s)-(3-(2-thienyl)alanyl)-(s)-seryl-(r)-((1,2,3,4-tetrahydro-3-isoquinolyl)carbonyl)-(2s,3as,7as)-((hexahydro-2-indolinyl)carbonyl)-(s)-arginine acetate (salt)

Cas Number

138614-30-9

Unique Ingredient Identifier (UNII)

325O8467XK

About Icatibant Acetate

Icatibant Acetate is the acetate salt form of icatibant, an antagonist of the human bradykinin B2 receptor (B2R), that can be used for the treatment of hereditary angioedema (HAE). Upon administration, icatibant targets and binds to B2R, thereby preventing bradykinin from binding to the B2R. This may prevent bradykinin/B2R-mediated vasodilation, the resulting increase in vascular permeability, and the swelling, inflammation, and pain associated with HAE. This may also prevent or improve pulmonary edema not associated with HAE and improve the associated decrease in blood oxygen levels.

Icatibant Acetate Manufacturers

A Icatibant Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Icatibant Acetate, including repackagers and relabelers. The FDA regulates Icatibant Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Icatibant Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Icatibant Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Icatibant Acetate Suppliers

A Icatibant Acetate supplier is an individual or a company that provides Icatibant Acetate active pharmaceutical ingredient (API) or Icatibant Acetate finished formulations upon request. The Icatibant Acetate suppliers may include Icatibant Acetate API manufacturers, exporters, distributors and traders.

click here to find a list of Icatibant Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Icatibant Acetate USDMF

A Icatibant Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Icatibant Acetate active pharmaceutical ingredient (API) in detail. Different forms of Icatibant Acetate DMFs exist exist since differing nations have different regulations, such as Icatibant Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Icatibant Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Icatibant Acetate USDMF includes data on Icatibant Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Icatibant Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Icatibant Acetate suppliers with USDMF on PharmaCompass.

Icatibant Acetate Manufacturers | Traders | Suppliers

Icatibant Acetate Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.